LOGIMAX

This brand name is authorized in Cyprus, Germany, Spain, Finland, France, Hong Kong, Mexico

Active ingredients

The drug LOGIMAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Felodipine UNII OL961R6O2C - FELODIPINE

Felodipine is a vascular selective calcium antagonist, which lowers arterial blood pressure by decreasing systemic vascular resistance. Felodipine is effective in all grades of hypertension. Read about Felodipine

2 Metoprolol UNII TH25PD4CCB - METOPROLOL SUCCINATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOGIMAX Prolonged-release tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07FB02	Metoprolol and felodipine	C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FB Beta blocking agents, selective, and other antihypertensives
Discover more medicines within C07FB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01563509, 06132352, 06132369, 06132375, 06142095, 09944576, 15746886
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60612
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 172627, 439489
Country: FR	Base de données publique des médicaments	Identifier(s): 61950444
Country: HK	Department of Health Drug Office	Identifier(s): 38314
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 346M96